Polymorphisms of SPINK1 N34S and CFTR in patients with sporadic and familial pancreatic cancer

Cancer Biology and Therapy

Volumn 2, Issue 6, 2003, Pages 652-655

  Matsubayashi, Hiroyuki ^a,b   Fukushima, Noriyoshi ^a   Sato, Norihiro ^a   Brune, Kieran ^a   Canto, Marcia ^a   Yeo, Charles J ^a   Hruban, Ralph H ^a   Kern, Scott E ^a   Goggins, Michael ^a  

^a DEPARTMENT OF PATHOLOGY   (United States)

^b TOKYO MEDICAL UNIVERSITY   (Japan)

Author keywords

CFTR; Familial; Germline mutation; Pancreatic carcinoma; Pancreatitis; SPINK1

Indexed keywords

CARRIER PROTEIN; CFTR PROTEIN, HUMAN; SPINK1 PROTEIN, HUMAN; TRANSMEMBRANE CONDUCTANCE REGULATOR;

ADENOCARCINOMA; AGED; ARTICLE; CHRONIC DISEASE; COMPARATIVE STUDY; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; HETEROZYGOTE; HUMAN; MIDDLE AGED; MUTATION; PANCREAS TUMOR; PANCREATITIS; PATHOLOGY; PEDIGREE; PREVALENCE; RETROSPECTIVE STUDY; RISK FACTOR;

ADENOCARCINOMA; AGED; CARRIER PROTEINS; CHRONIC DISEASE; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; GENETIC PREDISPOSITION TO DISEASE; HETEROZYGOTE; HUMANS; MIDDLE AGED; MUTATION; PANCREATIC NEOPLASMS; PANCREATITIS; PEDIGREE; POLYMORPHISM, GENETIC; PREVALENCE; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 3042583844     PISSN: 15384047     EISSN: 15558576     Source Type: Journal    
DOI: 10.4161/cbt.2.6.530     Document Type: Article

References (33)

1. Klein AP, Hruban RH, Brune KA, et al. Familial pancreatic cancer. Cancer J 2001; 7:266-73.
2. Hruban RH, Petersen GM, Goggins M, et al. Familial pancreatic cancer. Ann Oncol 1999; 10:69-73.
3. Goggins M, Schutte M, Lu J, et al. Germline BRCA2 gene mutations in patients with apparently sporadic pancreatic carcinomas. Cancer Res 1996; 56:5360-4. (Pubitemid 27011364)
4. Lynch HT, Brand RE, Lynch JF, et al. Genetic counseling and testing for germline p16 mutations in two pancreatic cancer-prone families. Gastroenterology 2000; 119:1756-60. (Pubitemid 32198701)
5. Su GH, Hruban RH, Bansal RK, et al. Germline and somatic mutations of the STK11/LKB1 Peutz-Jeghers gene in pancreatic and biliary cancers. Am J Pathol 1999; 154:1835-40. (Pubitemid 29262866)
6. Lal G, Liu G, Schmocker B, et al. Inherited predisposition to pancreatic adenocarcinoma: Role of family history and germ-line p16, BRCA1, and BRCA2 mutations. Cancer Res 2000; 60:409-16. (Pubitemid 30070770)
7. Van Der Heijden MS, Yeo CJ, Hruban RH, et al. Fanconi anemia gene mutations in youngonset pancreatic cancer. Cancer Res 2003; 63:2585-8. (Pubitemid 36605199)
8. Eberle MA, Pfutzer R, Pogue-Geile KL, et al. A new susceptibility locus for autosomal dominant pancreatic cancer maps to chromosome 4q32-34. Am J Hum Genet 2002; 70:1044-8. (Pubitemid 34259323)
9. Lowenfels AB, Maisonneuve P, Whitcomb DC. Risk factors for cancer in hereditary pancreatitis. International Hereditary Pancreatitis Study Group Med Clin North Am 2000; 84:565-73. (Pubitemid 30346152)
10. Wong T, Howes N, Threadgold J, et al. Molecular diagnosis of early pancreatic ductal adenocarcinoma in high- risk patients. Pancreatology 2001; 1:486-509. (Pubitemid 33681752)
11. Charnley R. Hereditary pancreatitis. World J Gatsroenterology 2003; 9:1-4.
12. Neglia JP, FitzSimmons SC, Maisonneuve P, et al. The risk of cancer among patients with cystic fibrosis. Cystic Fibrosis and Cancer Study Group N Engl J Med 1995; 332:494-9.
13. Whitcomb DC, Applebaum S, Martin SP. Hereditary pancreatitis and pancreatic carcinoma. Ann N Y Acad Sci 1999; 880:201-9.
14. Rinderknecht H. Pancreatic secretory enzymes. 2ed. New York: Raven: 1993.
15. Laskowski M, Jr., Kato I. Protein inhibitors of proteinases. Annu Rev Biochem 1980; 49:593-626.
16. Drenth JP, te Morsche R, Jansen JB. Mutations in serine protease inhibitor Kazal Type 1 are strongly associated with chronic pancreatitis. Gut 2002; 50:687-92.
17. Threadgold J, Greenhalf W, Ellis I, et al. The N34S mutation of SPINK1 (PSTI) is associated with a familial pattern of idiopathic chronic pancreatitis but does not cause the disease. Gut 2002; 50:675-81. (Pubitemid 34407496)
18. Witt H, Luck W, Hennies HC, et al. Mutations in the gene encoding the serine protease inhibitor, Kazal Type 1 are associated with chronic pancreatitis. Nat Genet 2000; 25:213-6.
19. Pfutzer RH, Barmada MM, Brunskill AP, et al. SPINK1/PSTI polymorphisms act as disease modifiers in familial and idiopathic chronic pancreatitis. Gastroenterology 2000; 119:615-23.
20. Noone PG, Zhou Z, Silverman LM, et al. Cystic fibrosis gene mutations and pancreatitis risk: Relation to epithelial ion transport and trypsin inhibitor gene mutations. Gastroenterology 2001; 121:1310-9. (Pubitemid 33140448)
21. Chen JM, Mercier B, Audrezet MP, et al. Mutations of the pancreatic secretory trypsin inhibitor (PSTI) gene in idiopathic chronic pancreatitis. Gastroenterology 2001; 120:1061-4. (Pubitemid 32193207)
22. Witt H, Luck W, Becker M, et al. Mutation in the SPINK1 trypsin inhibitor gene, alcohol use, and chronic pancreatitis. JAMA 2001; 285:2716-7. (Pubitemid 32525366)
23. Malats N, Casals T, Porta M, et al. Cystic fibrosis transmembrane regulator (CFTR) ΔF508 mutation and 5T allele in patients with chronic pancreatitis and exocrine pancreatic cancer. PANKRAS II Study Group. Gut 2001; 48:70-4. (Pubitemid 32042644)
24. Cohn JA, Friedman KJ, Noone PG, et al. Relation between mutations of the cystic fibrosis gene and idiopathic pancreatitis. N Engl J Med 1998; 339:653-8. (Pubitemid 28402089)
25. Sharer N, Schwarz M, Malone G, et al. Mutations of the cystic fibrosis gene in patients with chronic pancreatitis. N Engl J Med 1998; 339:645-52. (Pubitemid 28402088)
26. Liu X, Jiang Q, Mansfield SG, et al. Partial correction of endogenous ΔF508 CFTR in human cystic fibrosis airway epithelia by spliceosome-mediated RNA trans-splicing. Nat Biotechnol 2002; 20:47-52. (Pubitemid 34044914)
27. Southey MC, Batten L, Andersen CR, et al. CFTR ΔF508 carrier status, risk of breast cancer before the age of 40 and histological grading in a population-based case-control study. Int J Cancer 1998; 79:487-9. (Pubitemid 28445270)
28. Schoni MH, Maisonneuve P, Schoni-Affolter F, et al. Cancer risk in patients with cystic fibrosis: The European data. CF/CSG Group. J R Soc Med 1996; 89:38-43.
29. Sheldon CD, Hodson ME, Carpenter LM, et al. A cohort study of cystic fibrosis and malignancy. Br J Cancer 1993; 68:1025-8. (Pubitemid 23315243)
30. Matsubayashi H, Sato N, Fukushima N, et al. Methylation of cyclin D2 is observed frequently in pancreatic cancer but is also an age-related phenomenon in gastrointestinal tissues. Clin Cancer Res 2003; 9:1446-52. (Pubitemid 36418400)
31. Chandak GR, Idris MM, Reddy DN, et al. Mutations in the pancreatic secretory trypsin inhibitor gene (PSTI/SPINK1) rather than the cationic trypsinogen gene (PRSS1) are significantly associated with tropical calcific pancreatitis. J Med Genet 2002; 39:347-51. (Pubitemid 34526356)
32. Casals T, Ramos MD, Gimenez J, et al. High heterogeneity for cystic fibrosis in Spanish families: 75 mutations account for 90% of chromosomes. Hum Genet 1997; 101:365-70. (Pubitemid 28197535)
33. Schneider A, Suman A, Rossi L, et al. SPINK1/PSTI mutations are associated with tropical pancreatitis and Type II diabetes mellitus in Bangladesh. Gastroenterology 2002; 123:1026-30.